2007
DOI: 10.1016/j.ygyno.2007.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Successful salvage of a relapsed high risk gestational trophoblastic neoplasia patient using capecitabine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 4 publications
0
8
0
Order By: Relevance
“…Successful use of capecitabine as single-agent salvage chemotherapy has been reported. 120,121 Groups in Asia have also reported on fluorouracil, primarily in combination with dactinomycin. 70…”
Section: Salvage Chemotherapymentioning
confidence: 99%
“…Successful use of capecitabine as single-agent salvage chemotherapy has been reported. 120,121 Groups in Asia have also reported on fluorouracil, primarily in combination with dactinomycin. 70…”
Section: Salvage Chemotherapymentioning
confidence: 99%
“… 2 , 3 The agents that have shown response in refractory GTT include ifosfamide, 4 gemcitabine, 5 and capecitabine. 6 Ifosfamide alone or in combination (eg, combined etoposide, ifosfamide, and cisplatin) are active in patients with refractory disease. 4 Gemcitabine plus cisplatin has shown activity in a patient who progressed after combination chemotherapy and EP-EMA.…”
Section: Discussionmentioning
confidence: 99%
“… 5 Capecitabine alone can produce complete and long-lasting remission in refractory GTT. 6 If there is biochemical remission, then it could be consolidated with high-dose chemotherapy supported with peripheral blood stem cells. 7 …”
Section: Discussionmentioning
confidence: 99%
“…In patients who resisted second line chemotherapy, third line chemotherapy may be considered. Several regimens were proposed as third line treatment such as TP/TE, BEP, ICE, Carboplatin/ Gemcitabine (Bianconi et al, 2007;Wong et al, 2008;Patel et al, 2010;Feng et al, 2011;Alazzam et al, 2012;Lurain et al, 2012). The efficacy of those regimens was acceptable (Bianconi et al, 2007;Feng et al, 2011;Lurain et al, 2012).…”
Section: Discussionmentioning
confidence: 99%